Avivagen Stock Today

VIV Stock  CAD 0.1  0.005  5.00%   
Market Performance
0 of 100
Odds Of Distress
Over 89
Avivagen is selling for under 0.095 as of the 6th of February 2023; that is -5 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.095. Avivagen has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Avivagen are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of January 2023 and ending today, the 6th of February 2023. Click here to learn more.
Fiscal Year End
October
Category
Healthcare
ISIN
CA05382F2026
Avivagen Inc. develops and commercializes various products to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animals own health defenses. The company was formerly known as Chemaphor, Inc. and changed its name to Avivagen Inc.in May 2012. The company has 77.19 M outstanding shares of which 1.18 K shares are at this time shorted by private and institutional investors with about 0.04 days to cover all short positions. More on Avivagen

Moving together with Avivagen

+0.62CWEBCharlottes Web HoldingsPairCorr

Avivagen Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Avivagen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Avivagen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO and President and DirectorCameron Groome
Macroaxis Advice
The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Avivagen's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
Avivagen (VIV) is traded on TSX Venture Exchange in Canada and employs 13 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.33 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Avivagen's market, we take the total number of its shares issued and multiply it by Avivagen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Avivagen classifies itself under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 77.19 M outstanding shares of which 1.18 K shares are at this time shorted by private and institutional investors with about 0.04 days to cover all short positions. Avivagen has accumulated about 3.23 M in cash with (4.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
Check Avivagen Probability Of Bankruptcy
Ownership
Avivagen holds a total of seventy-seven million one hundred eighty-seven thousand four hundred outstanding shares. Almost 99.0 percent of Avivagen outstanding shares are held by regular investors with 1.43 (percent) owned by insiders and only 0.0 % by other corporate entities. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation

Check Avivagen Ownership Details

Avivagen Stock Price Odds Analysis

Depending on a normal probability distribution, the odds of Avivagen jumping above the current price in 90 days from now is about 47.89%. The Avivagen probability density function shows the probability of Avivagen stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Avivagen has a beta of -0.4686. This entails as returns on benchmark increase, returns on holding Avivagen are expected to decrease at a much lower rate. During the bear market, however, Avivagen is likely to outperform the market. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Avivagen is significantly underperforming NYSE Composite.
  Odds Below 0.095HorizonTargetOdds Above 0.095
52.01%90 days
 0.1 
47.89%
Based on a normal probability distribution, the odds of Avivagen to move above the current price in 90 days from now is about 47.89 (This Avivagen probability density function shows the probability of Avivagen Stock to fall within a particular range of prices over 90 days) .

Avivagen Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Avivagen market risk premium is the additional return an investor will receive from holding Avivagen long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Avivagen. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Avivagen's alpha and beta are two of the key measurements used to evaluate Avivagen's performance over the market, the standard measures of volatility play an important role as well.

Avivagen Stock Against Markets

Picking the right benchmark for Avivagen stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Avivagen stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Avivagen is critical whether you are bullish or bearish towards Avivagen at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Avivagen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Cryptocurrency Center Now

   

Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
All  Next Launch Module

Avivagen Corporate Directors

Avivagen corporate directors refer to members of an Avivagen board of directors. The board of directors generally takes responsibility for the Avivagen's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Avivagen's board members must vote for the resolution. The Avivagen board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
David Hankinson - Executive DirectorProfile
Louis Hui - Director - Business DevelopmentProfile
David Allan - DirectorProfile
Amin Khalifa - Independent DirectorProfile

Invested in Avivagen?

The danger of trading Avivagen is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Avivagen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Avivagen. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Avivagen is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Also, please take a look at World Market Map. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for analysis

When running Avivagen price analysis, check to measure Avivagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avivagen is operating at the current time. Most of Avivagen's value examination focuses on studying past and present price action to predict the probability of Avivagen's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Avivagen's price. Additionally, you may evaluate how the addition of Avivagen to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bond Directory
Find actively traded corporate debentures issued by US companies
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Please note, there is a significant difference between Avivagen's value and its price as these two are different measures arrived at by different means. Investors typically determine Avivagen value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avivagen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.